ATXN7: Ataxin-7 Gene in Spinocerebellar Ataxia and Disease
Comprehensive genomic and functional overview of ATXN7, its role in SCA7, and expression data.
Gene Information Card
| Symbol | ATXN7 |
|---|---|
| Full Name | Ataxin 7 |
| Gene Type | protein-coding |
| Chromosomal Location | 3p14.1 |
| NCBI Gene ID | 6314 ncbi.nlm.nih.gov/gene/6314 |
| Ensembl ID | ENSG00000163635 |
| UniProt ID | O15265 |
| OMIM ID | 607640 |
| HGNC ID | 10560 |
| Aliases | SCA7, OPCA3, ADCAII |
Description
ATXN7 encodes ataxin-7, a component of the STAGA (SPT3-TAF9-ADA-GCN5 acetyltransferase) transcriptional coactivator complex. The protein contains a polyglutamine tract in its N-terminal region; expansion of this tract (≥37 repeats) causes spinocerebellar ataxia type 7 (SCA7), a neurodegenerative disorder characterized by progressive cerebellar ataxia and retinal degeneration. Ataxin-7 is involved in chromatin remodeling, transcription regulation, and DNA repair.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Spinocerebellar ataxia type 7 (SCA7) | Expanded polyglutamine tract in ataxin-7 leads to protein misfolding, aggregation, and transcriptional dysregulation via STAGA complex impairment. | OMIM #164500; ClinVar; multiple peer-reviewed studies. |
| Retinal degeneration (SCA7-associated) | Mutant ataxin-7 disrupts photoreceptor-specific gene expression through aberrant STAGA complex recruitment. | OMIM; NCBI GeneReviews. |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Cerebellum | 12.5 | Medium |
| Cerebral cortex | 8.3 | Low |
| Retina | 15.2 | Medium |
| Testis | 20.1 | High |
| Heart | 6.7 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (neuroblastoma) | 18.4 | Neuronal model; used in SCA7 studies |
| HEK293 (embryonic kidney) | 22.1 | Common overexpression system |
| HeLa (cervical carcinoma) | 14.7 | Epithelial; STAGA complex studies |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| CAG repeat expansion (≥37 repeats) | trinucleotide repeat expansion | 0.0001% (rare) | Gain-of-function: toxic polyglutamine protein aggregates; transcriptional dysregulation. |
| c.892C>T (p.Arg298*) | nonsense | <0.001% | Loss-of-function: premature truncation; not associated with SCA7. |
Mutation functional classification
Loss of Function (LOF)
Rare nonsense/frameshift variants (e.g., p.Arg298*) reduce ataxin-7 protein levels; not linked to SCA7 phenotype.
Gain of Function (GOF)
Expanded polyglutamine tract (≥37 repeats) confers toxic gain-of-function via aggregation and aberrant protein interactions.
Dominant Negative (DN)
Mutant ataxin-7 may interfere with STAGA complex assembly and function, contributing to transcriptional dysregulation.
View complete mutation data:
Gene Ontology (GO)
Pathways
• STAGA complex (SPT3-TAF9-ADA-GCN5 acetyltransferase) - chromatin remodeling
• Polyglutamine disease pathway (KEGG: hsa05016)
Protein Summary
Ataxin-7 is a 892-amino acid protein (UniProt O15265) containing a polyglutamine tract (normally 4-35 repeats), a SCA7 domain, and a C-terminal region that mediates interaction with STAGA complex subunits. It localizes to the nucleus and functions in transcriptional regulation via histone acetylation. Pathogenic expansion of the polyglutamine tract leads to protein aggregation and neurodegeneration.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ATXN7 Knockout HEK293 Cell Line | EDJ-KQ5714 | Human | 6314 | Details Get a Quote |
| ATXN7L1 Knockout HEK293 Cell Line | EDJ-KQ9003 | Human | 222255 | Details Get a Quote |
| ATXN7L2 Knockout HEK293 Cell Line | EDJ-KQ9006 | Human | 127002 | Details Get a Quote |
| ATXN7L3B Knockout HEK293 Cell Line | EDJ-KQ12493 | Human | 552889 | Details Get a Quote |
| ATXN7 Knockout A-549 Cell Line | EDJ-KQ29099 | Human | 6314 | Details Get a Quote |
| ATXN7 Knockout HCT 116 Cell Line | EDJ-KQ29100 | Human | 6314 | Details Get a Quote |
| ATXN7 Knockout HeLa Cell Line | EDJ-KQ29101 | Human | 6314 | Details Get a Quote |
| ATXN7L3B Knockout A-549 Cell Line | EDJ-KQ40176 | Human | 552889 | Details Get a Quote |
| ATXN7L3B Knockout HCT 116 Cell Line | EDJ-KQ41462 | Human | 552889 | Details Get a Quote |
| ATXN7L3B Knockout HeLa Cell Line | EDJ-KQ41463 | Human | 552889 | Details Get a Quote |
| ATXN7L1 Knockout A-549 Cell Line | EDJ-KQ35442 | Human | 222255 | Details Get a Quote |
| ATXN7L1 Knockout HCT 116 Cell Line | EDJ-KQ35443 | Human | 222255 | Details Get a Quote |
| ATXN7L1 Knockout HeLa Cell Line | EDJ-KQ35444 | Human | 222255 | Details Get a Quote |
| ATXN7L2 Knockout A-549 Cell Line | EDJ-KQ35447 | Human | 127002 | Details Get a Quote |
| ATXN7L2 Knockout HCT 116 Cell Line | EDJ-KQ35448 | Human | 127002 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records